Literature DB >> 11136689

Evidence for joint genetic control of insulin sensitivity and systolic blood pressure in hispanic families with a hypertensive proband.

A H Xiang1, S P Azen, L J Raffel, S Tan, L S Cheng, J Diaz, E Toscano, P C Henderson, H N Hodis, W A Hsueh, J I Rotter, T A Buchanan.   

Abstract

BACKGROUND: The clustering of hypertension, insulin resistance, and obesity remains unexplained. We tested for genetic and nongenetic influences on the association among these traits in Hispanic families with hypertension. METHODS AND
RESULTS: Blood pressure and body mass index (BMI) were measured in 331 members of 73 Hispanic families in which an index case (proband) had hypertension. Insulin sensitivity (S(I)) was measured by euglycemic clamp in 287 probands and their spouses (parents' generation) or their adult offspring. Correlation analysis examined relationships among traits within and between generations. Path analysis estimated genetic and nongenetic contributions to variability in systolic blood pressure (SBP), S(I), and the correlation between them. In the offspring, there was a significant correlation between individuals for each trait, as well as significant correlations within and between individuals for all possible pairs of traits. Between generations, SBP, S(I), and BMI in parents correlated with the same traits in their offspring; BMI in parents correlated with S(I) and SBP in offspring; and S(I) in parents correlated with SBP in offspring. Path analysis estimated that among offspring, genetic effects unrelated to BMI accounted for 60.8% of the variation in SBP, 36.8% of the variation in S(I), and 31.5% of the correlation between SBP and S(I) after adjustment for age and sex. Heritable effects related to BMI accounted for an additional 14.0% of variation in SBP, 26.8% of variation in S(I), and 56.3% of variation in their correlation.
CONCLUSIONS: Clustering of hypertension and insulin resistance in Hispanic Americans is accounted for in part by heritable factors both associated with and independent of BMI.

Entities:  

Mesh:

Year:  2001        PMID: 11136689     DOI: 10.1161/01.cir.103.1.78

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

1.  Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension.

Authors:  Jonathan S Williams; Bindu Chamarthi; Mark O Goodarzi; Luminita H Pojoga; Bei Sun; Amanda E Garza; Benjamin A Raby; Gail K Adler; Paul N Hopkins; Nancy J Brown; Xavier Jeunemaitre; Claudio Ferri; Rui Fang; Thiago Leonor; Jinrui Cui; Xiuqing Guo; Kent D Taylor; Yii-Der Ida Chen; Anny Xiang; Leslie J Raffel; Thomas A Buchanan; Jerome I Rotter; Gordon H Williams; Yujiang Shi
Journal:  Am J Hypertens       Date:  2012-04-26       Impact factor: 2.689

2.  Lysine-Specific Demethylase-1 Deficiency Increases Agonist Signaling Via the Mineralocorticoid Receptor.

Authors:  Thitinan Treesaranuwattana; Kelly Yin Han Wong; Danielle L Brooks; Chee Sin Tay; Gordon H Williams; Jonathan S Williams; Luminita H Pojoga
Journal:  Hypertension       Date:  2020-03-11       Impact factor: 10.190

3.  Variants of the caveolin-1 gene: a translational investigation linking insulin resistance and hypertension.

Authors:  Luminita H Pojoga; Patricia C Underwood; Mark O Goodarzi; Jonathan S Williams; Gail K Adler; Xavier Jeunemaitre; Paul N Hopkins; Benjamin A Raby; Jessica Lasky-Su; Bei Sun; Jinrui Cui; Xiuqing Guo; Kent D Taylor; Yii-Der Ida Chen; Anny Xiang; Leslie J Raffel; Thomas A Buchanan; Jerome I Rotter; Gordon H Williams
Journal:  J Clin Endocrinol Metab       Date:  2011-05-25       Impact factor: 5.958

Review 4.  Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease.

Authors:  Mark O Goodarzi; Jerome I Rotter
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

5.  The Association of Estrogen Receptor-β Gene Variation With Salt-Sensitive Blood Pressure.

Authors:  Worapaka Manosroi; Jia Wei Tan; Chevon M Rariy; Bei Sun; Mark O Goodarzi; Aditi R Saxena; Jonathan S Williams; Luminita H Pojoga; Jessica Lasky-Su; Jinrui Cui; Xiuqing Guo; Kent D Taylor; Yii-Der I Chen; Anny H Xiang; Willa A Hsueh; Leslie J Raffel; Thomas A Buchanan; Jerome I Rotter; Gordon H Williams; Ellen W Seely
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

6.  Glucose, insulin, and incident hypertension in the multi-ethnic study of atherosclerosis.

Authors:  Gregory Levin; Bryan Kestenbaum; Yii-Der Ida Chen; David R Jacobs; Bruce M Psaty; Jerome I Rotter; David S Siscovick; Ian H de Boer
Journal:  Am J Epidemiol       Date:  2010-10-20       Impact factor: 4.897

7.  Systematic evaluation of validated type 2 diabetes and glycaemic trait loci for association with insulin clearance.

Authors:  M O Goodarzi; X Guo; J Cui; M R Jones; T Haritunians; A H Xiang; Y-D I Chen; K D Taylor; T A Buchanan; W A Hsueh; L J Raffel; J I Rotter
Journal:  Diabetologia       Date:  2013-03-14       Impact factor: 10.122

8.  Association of insulin sensitivity and glucose tolerance with the c.825C>T variant of the G protein beta-3 subunit gene.

Authors:  Daniel Kopf; Li S-C Cheng; Petra Blandau; Willa Hsueh; Leslie J Raffel; Thomas A Buchanan; Anny H Xiang; Richard C Davis; Jerome I Rotter; Hendrik Lehnert
Journal:  J Diabetes Complications       Date:  2008-04-16       Impact factor: 2.852

9.  Classification of Type 2 Diabetes Genetic Variants and a Novel Genetic Risk Score Association With Insulin Clearance.

Authors:  Mark O Goodarzi; Nicholette D Palmer; Jinrui Cui; Xiuqing Guo; Yii-Der I Chen; Kent D Taylor; Leslie J Raffel; Lynne E Wagenknecht; Thomas A Buchanan; Willa A Hsueh; Jerome I Rotter
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

10.  Insulin clearance: confirmation as a highly heritable trait, and genome-wide linkage analysis.

Authors:  X Guo; J Cui; M R Jones; T Haritunians; A H Xiang; Y-D I Chen; K D Taylor; T A Buchanan; R C Davis; W A Hsueh; L J Raffel; J I Rotter; M O Goodarzi
Journal:  Diabetologia       Date:  2012-05-16       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.